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Point-of-care (POC) diagnostic tests with good performances are needed for diagnosing 
failure of transfer of passive immunity (FTPI) in foals. A commercially available 
turbidometric immunoassays (TIA)-based POC test (POC-TIA) has not been validated in 
horses. The objective of the study was to validate a POC-TIA and compare results of POC-
TIA, a POC-ELISA and radial immunodiffusion (RID).  
Blood samples (n=127) from 48 hospitalized foals were used and a prospective validation 
study was performed. IgG concentrations were measured using RID (gold standard), POC-
TIA and POC-ELISA. Agreement between assays was assessed using Bland-Altman analysis. 
Sensitivity and specificity were calculated using ROC curves. Inter- and intra-assay 
coefficients of variation (CVs) and linearity were evaluated for POC-TIA.  
The results show the mean bias between RID and POC-TIA was -4, 27 and 308 mg/dL for 
samples with IgG concentrations of <400, 400–800 and >800 mg/dL, respectively. Sensitivity 
and specificity at optimal cut-off were 94% and 100% for the POC-TIA and 94% and 100% 
for the POC-ELISA to detect IgG <400 mg/dL, and 85% and 87% (POC-TIA) and 69% and 
79% (POC-ELISA) to detect IgG ≤800 mg/dL. Intra- and inter-assay CVs for POC-TIA 
ranged between 1.6–3.8% and 11.9-18.8%, respectively. 
In conclusion, the POC-TIA provided unambiguous results and had sufficient sensitivity, 
specificity, accuracy and precision to be used as an alternative to other POC tests to assess 
FTPI in foals.  
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Point-of-Care (POC) IgG Test dienen der schnellen Diagnose des „failure of transfer of 
passive immunity“ (FTPI) beim Fohlen. Ein Turbidometrische Immunoassays (TIA)-basierter 
POC-Test (POC-TIA) ist auf dem Markt, ist aber nicht validiert. Das Ziel dieser Studie ist die 
Validierung des POC-TIA sowie der Vergleich der Ergebnisse des POC-TIA mit einem POC-
ELISA und dem "radial immundiffusion assay" (RID).  
Eine prospektive Validierungsstudie wurde mit Blutproben (n=127) von 48 hospitalisierten 
Fohlen durchgeführt. Die IgG-Konzentrationen wurden mittels RID (Gold Standard) sowie 
POC-TIA und POC-ELISA bestimmt. Die Übereinstimmung zwischen den RID und POC-
TIA wurde mit der Bland-Altman-Analyse beurteilt und Sensitivität und Spezifität von POC-
TIA und POC-ELISA mit ROC-Kurven berechnet. Inter- und Intra-Assay-
Variationskoeffizienten (CVs) und Linearität wurden für den POC-TIA ausgewertet.  
Die Ergebnisse der Studie zeigten, dass der mittlere Bias zwischen RID und POC-TIA -4 
mg/dl, 27 mg/dL und 308 mg/dL für Proben mit IgG Konzentrationen von <400, 400-800 und 
>800 mg/dL betrug. Sensitivität und Spezifität beim optimalem Cut-off waren 94% und 100% 
für den POC-TIA und 94% und 100% für den POC-ELISA zur Detektion von IgG <400 
mg/dL und 85% und 87% (POC-TIA) und 69% und 79% (POC-ELISA) zur Detektion von 
IgG ≤800 mg/dL.  
Der POC-TIA hat adequate Sensitivität, Spezifität, Genauigkeit und Präzision und kann als 
Alternative zu anderen POC Tests zur Diagnose von FTPI eingesetzt werden. 
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Abstract 
Point-of-care (POC) diagnostic tests with good sensitivity and specificity are needed for 
diagnosing failure of transfer of passive immunity (FTPI) in foals. Turbidometric 
immunoassays (TIA) have these characteristics and provide quantitative results. A 
commercially available TIA-based POC test (POC-TIA) has not been validated in horses 
Objective of the study was to validate a POC-TIA and compare results of POC-TIA, a POC-
ELISA and radial immunodiffusion (RID). Heparinized blood samples (n=127) from 48 
hospitalized foals (<12h to 48 days) were used.  A prospective validation study was 
performed. IgG concentrations were measured using RID (gold standard), POC-TIA and 
POC-ELISA. Agreement between assays was assessed using Bland-Altman analysis. 
Sensitivity and specificity were calculated using ROC curves. Inter- and intra-assay 
coefficients of variation (CVs) and linearity were evaluated for POC-TIA. The results show 
the mean bias (95% limits of agreement) between RID and POC-TIA was -4 (-185 to 176), 27 
(-201 to 255) and 308 (-377 to 993) mg/dL for samples with IgG concentrations of <400, 
400–800 and >800 mg/dL, respectively. Sensitivity and specificity at optimal cut-off were 
94% and 100% for the POC-TIA and 94% and 100% for the POC-ELISA to detect IgG <400 
mg/dL, and 85% and 87% (POC-TIA) and 69% and 79% (POC-ELISA) to detect IgG ≤800 
mg/dL. Intra- and inter-assay CVs for POC-TIA ranged between 1.6–3.8% and 11.9-18.8%, 
respectively. Linearity of the dilution series was preserved (R2 >0.96). In conclusion, the 
POC-TIA provided unambiguous results and had sufficient sensitivity, specificity, accuracy 





Failure of transfer of passive immunity (FTPI) is common in neonatal foals and predisposes 
them to severe infections.1,2 Early detection of FTPI is therefore important to ensure adequate 
and timely treatment.1,3,4 Immunoglobulin G (IgG) concentrations of >800 mg/dL measured 
12–48h post natum are generally considered adequate,2 and FTPI is commonly defined as 
partial FTPI at IgG concentrations of 400-800 mg/dL or total FTPI at IgG concentrations 
<400 mg/dL.1,2 
A variety of quantitative and semi-quantitative methods have been used to determine IgG 
concentrations in neonatal foals,5-7 but radial immunodiffusion (RID) is considered the gold 
standard for the diagnosis of FTPI. However, RID has a long turnaround time, requires 
expertise in result interpretation and is costly.3,8 Serum electrophoresis has been suggested as 
an alternative gold standard to RID and may be more accurate and reliable in interpretation, 
but electrophoresis also requires specialized laboratory equipment and has a relatively long 
turnaround time.3,5,9,10 
Several rapid, inexpensive point-of-care tests for clinical use, including an ELISAa, zinc 
sulfate turbidity test, glutaraldehyde coagulation tests and latex agglutination tests, have been 
shown to have acceptable sensitivity and specificity.6,7,9,11 However, these tests provide only 
semi-quantitative results and are subject to interpretation error. Estimates of IgG 
concentrations based on serum total protein concentrations are considered unreliable1,5,6,12 and 
serum total globulins have limited sensitivity and specificity.2,3,13 
An automated turbidimetric immunoassay developed for quantitative IgG measurements in 
horses has adequate sensitivity and specificity, but testing requires a laboratory chemistry 
analyzer and is not convenient for use in daily practice.8 More recently, point-of-care 
analyzers that use the turbidimetric immunoassay technique have been developed. One of 
these analyzers has good sensitivity and specificity, but is no longer available.14 Another 
point-of-care turbidimetric analyzer (POC-TIAb) is currently marketed but there are thus far 
no published validation studies.  
The objective of this study was to validate the POC-TIAb and compare the performance of the 





Materials and Methods 
Animals 
Foals presented to the Equine Hospitals of the Universities of Zurich and Bern between 
February and July 2015 were included in the study. Foals were included if testing for FTPI 
was considered indicated by the attending clinicians. Multiple samples from the same foal 
were included when IgG concentrations were measured on multiple occasions throughout the 
course of treatment. The study was performed in accordance with the animal use guidelines of 
the Swiss legislation and approved by Cantonal Veterinary offices in Zurich and Bern. The 




Blood samples were obtained from the jugular vein by direct venipuncture or from an 
indwelling intravenous catheter. Six mL of native blood and 3 mL of heparinized blood were 
collected from each foal. Native blood was allowed to clot at room temperature for 60 
minutes before centrifugation at 1341 g for 11 minutes. The serum was then transferred to 
cryotubes and frozen at -80°C. Heparinized blood was centrifuged at 1341 g for 11 minutes at 
room temperature and plasma was used immediately to perform POC-TIAb and POC-ELISAa. 




The POC-TIAb and POC-ELISAa were run according to the manufacturers’ recommendations 
on heparinized plasma and evaluated by an experienced clinician. Results from POC-ELISAa 
were read before the results from POC-TIAb. Quality control of the POC-TIAb analyzer was 
carried out as recommended by the manufacturer throughout the study period. Linearity of the 
POC-TIAb dilution series was determined by linear regression using two plasma samples of 
high concentration measured undiluted and diluted with phosphate buffered saline at 
concentrations of 1:2, 1:4, 1:8, and 1:16. Intra-assay variability of the POC-TIAb was assessed 
by the coefficient of variation of ten replicate measurements of each of three samples, 
analyzed on the same setup of the assay. Inter-assay variability of the POC-TIAb was assessed 
by the CV of five replicate measurements of each of three samples (low, medium and high 
concentration), analyzed on different setups of the experiment. Coefficients of variation of 
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<25% were considered acceptable.16 Samples for intra-assay and inter-assay variability were 
randomly selected based on low (<400mg/dL), medium (400-800mg/dL) and high 
concentration (>800mg/dL).  
The frozen serum samples were shipped as a single batch on dry ice to MAI P/S laboratory 
(Spring Valley, WI) for RID analyses that were conducted using a commercial RID test kitc. 
The laboratory personnel were blinded to the results of the POC-TIAb and POC-ELISAa tests. 
Standard curves were performed on each individual RID plate using the manufacturer’s 
suggested protocol with serial dilutions of a commercial USDA certified Equine IgGd 
prepared with sterile goat serume. In addition to standards and unknowns, all RID plates 
included three control samples (high, 1900 mg/dL; mid, 950 mg/dL; and low, 475 mg/dL), 
standards supplied by the manufacturer of the RID plates and, on three plates, inter-assay 
(between plates) and intra-assay (with-in the same plate) replicates of three test samples 
chosen to represent high, mid and low levels of IgG. The same three laboratory technicians 
processed all samples to reduce subjectivity. The average of the three reads was reported as 





Descriptive statistics were used to summarize data. Agreement of the POC-TIAb with RID 
assay was evaluated using Bland–Altman analysis, whereby data were analyzed separately for 
samples with RID IgG concentrations of <400, 400–800 and >800 mg/dL, respectively. The 
mean bias, the 95% confidence interval (CI) of the mean bias, and the 95% limits of 
agreement (LOA) were calculated. Samples were categorized based on RID as ≤800 mg/dL 
(partial or total FTPI), and <400 mg/dL (total FTPI) to evaluate the performance of the POC-
TIAb and POC-ELISAa. Receiver operator characteristics (ROC) were used to determine the 
accuracy of POC-TIAb. The area under the ROC curve (AUC) was calculated and the Youden 
index (= maximum {sensitivity + specificity – 1}) was used to identify the optimal cut-off 
points for both sensitivity and specificity of the POC-TIAb to detect IgG concentrations < 400 
mg/dL (total FTPI) and ≤800 mg/dL (partial or total FTPI), respectively. Other cut-offs were 
chosen to maximize either specificity or sensitivity of the assay. Test characteristics at the 
respective cut-off values were summarized by reporting sensitivity, specificity, positive (+LR) 
and negative (-LR) likelihood ratios. Similarly, the performance of the POC-ELISAa was 
evaluated after generating ROC curves from the predicted probabilities from logistic 
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regression. In addition, classification agreement of samples with IgG >800 mg/dL, 400–800 
mg/dL and <400 mg/dL between POC-TIAb and RID assay and between POC-ELISAa and 
RID assay was evaluated using the Kappa statistic with linear weights. The level of 







A total of 127 samples were collected from 48 foals (87 samples from 20 foals presented to 
the Equine Hospital of University of Zurich and 40 samples from 28 foals presented to the 
Equine Hospital of the University of Bern). The sex of the foals was female in 18/48 (37.5%) 
and male in 30/48 (62.5%) of cases. The age at sampling ranged from <12 hours to 38 days, 
with a median of 4 days. Breeds included 19 Warmblood horses, 10 Freiberger, 8 ponies, 2 
donkeys, 2 draft horses, 2 Lusitanos and one each of Standardbred, Thoroughbred, Friesian, 
Quarter Horse, and Paso Fino. 
Presenting complaints recorded were FTPI (7/48), colic (7/48), sepsis (5/48), non-infectious 
orthopedic disease (5/48), healthy foals accompanying their sick mare (5/48), omphalitis 
(3/48), pneumonia (3/48), weakness (2/48), uroabdomen (2/48) and one each of prematurity, 
white muscle disease, inguinal hernia, soft tissue trauma, wry nose, fever, and esophageal 




A single blood sample was collected from 29 foals. Foals from which more than one sample 
was collected were: two samples (n=7), three samples (n=3), four samples (n=1), five samples 
(n=1), six samples (n=2), seven samples (n=1), nine samples (n=1), eleven samples (n=1), 
thirteen samples (n=1), and fourteen samples (n=1). A total of 67/127 samples were taken 
after plasma transfusion. Based on RID analyses, IgG concentrations were >800 mg/dL in 
75/127 (59%) samples, 400–800 mg/dL (partial FTPI) in 36/127 (28%) samples and <400 
mg/dL (total FTPI) in 16/127 (13%) samples. Any FTPI (partial or total) was present in 
52//127 (41%) of samples.  
 
Evaluation of POC-TIAb 
 
Linearity of the dilution series was preserved for the POC-TIAb assay (Figure 1, Table 1). 
Intra-assay variability was within acceptable limits with CVs between 1.6% and 3.8% (Table 
2). Inter-assay variability was higher (CVs between 11.9% and 18.8%) than intra-assay 
variability for all IgG concentrations (Table 2), but still within acceptable limits. 
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Agreement between POC-TIAb and RID using the Bland-Altman analyses revealed a mean 
bias of -4 mg/dL (95% CI, -53 to 45), 27 mg/dL (95% CI, -13 to 66) and 308 mg/dL (95% CI, 
-515 to -239) for samples with RID IgG concentrations of <400, 400–800 and >800, 
respectively (Figure 2). For samples with RID IgG concentrations of >800 mg/dL, a 
proportional error was evident with POC-TIAb showing a greater tendency to underestimate 
IgG concentrations as measured by RID assay at higher concentrations (Figure 2).  
The AUC of the ROC curves for the POC-TIA were 0.99 and 0.92 to detect IgG 
concentrations of <400 mg/dL and ≤800 mg/dL, respectively, when compared to the RID 
assay as the gold standard (Figure 3). The Youden index for detecting RID IgG 
concentrations of <400 mg/dL and ≤800 mg/dL, was associated with POC-TIAb cut-off 
concentrations of 299 mg/dL and 687 mg/dL, respectively. Cut-off concentrations for 
detecting RID IgG concentrations with highest sensitivity and specificity are given in Tables 
3 and 4. 
The weighted Kappa value characterizing agreement between POC-TIAb and RID assay for 
the classification of samples as IgG <400 mg/dL, 400–800 mg/dL and >800 mg/dL, 
respectively, was 0.64 (95% CI, 0.53–0.75). Total FTPI (<400 mg/dl) was falsely diagnosed 
by POC-TIAb in 5/20 (25%) samples, and 1/16 (6%) samples with total FTPI based on RID 
was missed by POC-TIAb; IgG concentrations ≤800 mg/dL (partial or total FTPI) were falsely 
diagnosed by POC-TIAb in 2/50 (4%) samples, and 27/75 (36%) samples with IgG 
concentrations ≤800 mg/dL (partial or total FTPI) based on RID were missed by POC-TIAb. 
 
Evaluation of POC-ELISAa 
 
Based on the POC-ELISAa results, 15/127 (12%) samples were classified as <400 mg/dL 
(total FTPI) and 52/127 (41%) as ≤800 mg/dL (partial or total FTPI). The AUC of the ROC 
curves for the POC-ELISA were 0.97 and 0.74 to detect IgG concentrations of <400 mg/dL 
(total FTPI) and ≤800 mg/dL (partial or total FTPI), respectively, when compared to the RID 
as the gold standard (Figure 3). Sensitivity, specificity and associated likelihood ratios to 
detect FTPI based on IgG concentrations <400mg/dL (total FTPI) and ≤800 mg/dL (partial or 
total FTPI), respectively, are presented in Tables 3 and 4. The Kappa value characterizing 
agreement between POC-ELISAa and RID for the classification of samples as IgG <400 
mg/dL, 400–800 mg/dL and >800 mg/dL was 0.63 (95% CI, 0.50–0.76). No samples were 
falsely diagnosed as total FTPI by POC-ELISAa, and 1/16 (6%) samples with total FTPI 
based on RID was missed by POC-ELISAa; IgG concentrations ≤800 mg/dL (partial or total 
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FTPI) were falsely diagnosed by POC-ELISA in 16/52 (31%) samples, and 16/52 (31%) 
samples with IgG concentrations ≤800 mg/dL (partial or total FTPI) based on RID were 






A quantitative point-of-care test offers a great advantage compared to most currently available 
assays marketed for the assessment of FTPI in foals that give only semi-quantitative results. 
In particular, semi-quantitative tests giving a result between 400 and 800 mg/dL do not allow 
clinicians to distinguish animals with IgG concentrations bordering on total FTPI from those 
with concentrations close to adequate levels. Moreover, the effects of treatment cannot be as 
closely monitored using semi-quantitative tests. The purpose of this study was to validate a 
quantitative POC-TIAb and compare IgG concentrations measured with RID and both the 
POC-TIAb and a widely-used semi-quantitative POC-ELISAa. The POC-TIAb showed both 
good linearity in dilution series and good precision, based on intra- and inter-assay CV. The 
test showed fair to good agreement with the gold standard RID and had better sensitivity and 
specificity than the POC-ELISAa in this study. 
 
The POC-TIAb evaluated in this study showed good linearity in dilution series. Intra-assay 
variability (CVs, 1.6–3.8%) was similar to that reported in a previous study (CV, 3%) 
evaluating an automated TIA performed on a routine laboratory chemistry analyzer.8 Inter-
assay variability (CVs, 11.9–18.8%) was considerably higher than that reported using an 
automated TIA (CVs, 1–4%).8 However, the range of values measured for inter-assay CVs in 
the current study was greater than that evaluated in the previous study. Moreover, both intra- 
and inter-assay CVs were well within acceptable limits of 25%.16,17 Several factors can 
influence the analytic performance of an assay. Small differences in sample handling and test 
setup can lead to variations. The more steps included in a protocol, the higher the chance for 
variation.17-19 This explains the slightly better coefficient of variation in the intra-assay 
experiment where measurements were carried out repeatedly compared to the inter-assay 
experiment, where the actual setup was repeated. The good analytic performance of the POC-
TIAb suggests that small differences in manipulation are not likely to lead to clinically 
relevant error in IgG measurement, and precise measurements of IgG at clinically relevant 
concentrations is possible. 
 
Agreement between POC-TIAb and the gold standard RID was good for samples with RID 
IgG concentrations of <400 mg/dL and 400–800 mg/dL. For samples with RID IgG 
concentrations of >800 mg/dL, both considerable bias and proportional error were evident 
with the POC-TIAb, measuring increasingly lower than RID assay with increasing IgG 
14 
 
concentrations. However, as IgG concentrations above 800mg/dL are considered to be 
adequate to protect foals against infections, this increasing bias is likely to be of little clinical 
importance. 
A test with high sensitivity is desirable when assessing FTPI, as failure to diagnose (and treat) 
FTPI may have serious sequela.14,20,21 Conversely, high specificity is necessary to avert 
unnecessary treatment of foals with plasma transfusions, which carries a risk of adverse 
effects and is associated with higher costs.22 The AUC of ROC curve analyses for POC-TIAb 
to detect RID IgG concentrations <400mg/dL (total FTPI) and ≤800mg/dL (partial or total 
FTPI) were both very high and considerably higher than that of POC-ELISAa. Moreover, 
optimal cut-off points based on the Youden index (i.e. 299 and 687 mg/dL) achieved a 
sensitivity and specificity similar or superior to those found with the POC-ELISAa, and those 
previously reported using a different POC-TIA assay (80% and 100%, respectively)14 and an 
automated TIA (63% and 92%, respectively).8 Likewise, optimal cut-off points achieved 
sensitivities and specificities similar or superior to those of the POC-ELISAa, and those 
previously reported using a different POC-TIA assay (76% and 100%, respectively)14 and 
using an automated TIA (81% and 86%, respectively).8 Although cut-off values determined 
by the Youden index resulted in some foals with FTPI being missed by POC-TIAb, this can be 
averted by selecting higher cut-off values of 488 and 804 mg/dL to detect IgG concentrations 
< 400 (total FTPI) and ≤800 mg/dL (total or partial FTPI, as measured by RID), respectively. 
These higher cut-off values result in sensitivities of 100% and 98.1%, respectively, decreasing 
the false negative rate at the expense of lower specificities. Results of the present study 
therefore suggest that the POC-TIAb provides sufficient diagnostic accuracy to assess FTPI in 
foals. 
 
Although the overall Kappa agreement to classify samples as <400 mg/dL, 400–800 mg/dL 
and >800 mg/dL was similar for the POC-TIAb and POC-ELISAa, results of ROC curve 
analyses suggest that POC-TIAb is superior to POC-ELISAa. However, as the POC-TIAb 
measured lower than RID, assay-specific cut-offs are necessary to achieve optimal 
performance. Indeed, use of 400 mg/dL and 800 mg/dL as cut-offs for the POC-TIAb would 
result in lower specificities than those achieved with Youden-index based cut-offs. 
 
Previous studies evaluating the POC-ELISAa have reported sensitivities and specificities 
ranging of 89–90% and 79–96%, respectively to detect RID <400 mg/dL, and 81–95% and 
52–95%, respectively to detect RID ≤800 mg/dL.6,12 However, differences in prevalences of 
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FTPI between studies and use of different RID assays makes direct comparison with other 
studies difficult. 
 
Multiple samples from foals were included in the study as samples were used to monitor the 
foal IgG concentrations over time after plasma transfusion. These samples were not 
considered repeated measures, as most of them received plasma for treatment of FTPI 
between sampling points.  
 
As evaluation of the POC-ELISAa is somewhat subjective and both the POC-TIAb and POC-
ELISAa were run by the same operator at the same time, results of the POC-ELISAa were read 
prior to performing the POC-TIAb. Therefore, results of POC-TIAb should not have 
influenced subjective reading of the POC-ELISAa. The POC-TIAb can be performed with 
both serum and plasma. In this study, plasma was used for convenience although serum was 
used for RID assays. However, as a previous study showed no difference in IgG 
concentrations between serum and plasma using an automated TIA assay, no significant effect 
of matrix is expected.21  
 
From a practical standpoint, the POC-TIAb was found to be easy to perform, rapid (run time 
of approximately 15 minutes) and the measured concentrations are displayed digitally, giving 
unambiguous results that are not subject to individual interpretation bias. 
 
In conclusion, the POC-TIAb showed fair to good overall performance and its use in practice 
can be considered as an alternative to other point-of-care tests for the diagnosis of FTPI in 
foals. Assay-specific cut-offs are necessary to achieve optimal accuracy compared to RID. 
 
Footnotes 
a  SNAP Foal IgG Test Kit, IDEXX Laboratories Inc, Westbrook, ME 
b  Rapid DVM testTM II, Value DiagnosticsTM, MAI Animal Health, Melksham, Wiltshire, UK 
c  RID Test for Equine IgG, product number 828411, Triple J Farms, Bellingham, WA, USA 
d  Secondary Reference Serum (SRS), Product Number 2011, Midland BioProducts, Boone, 
IA, USA  
e Equitech-Bio, Kerrville, TX, USA 
f  MedCalc, version 16.4.1 MedCalc Software bvba, Ostend, Belgium 
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Table 1 Analytic accuracy of POC-TIAb assessed by linear regression of dilution series in 











p (deviation from 
line of equality) 





0.0012 0.97 1.000 





0.0016 0.96 1.000 











High 2267 (86.5) 3.8 
Medium 658.8 (10.6) 1.6 
Low 361.3 (9.9) 2.7 
Inter-assay variability 
High 1653 (285.1) 17.2 
Medium 720 (135.4) 18.8 
Low 515.6 (61.5) 11.9 
CV, coefficient of variation. 





Table 3 Sensitivities, specificities and likelihood ratios of a point-of-care turbidimetric assay 
(POC-TIAb) and point-of-care ELISA (POC-ELISAa) to detect IgG concentrations <400 





















































AUC, area under the curve of ROC curve analysis; CI, confidence intervals; LR, likelihood 
ratio; RID, radial immunodiffusion; FTPI: failure of transfer of passive immunity 





Table 4 Sensitivities, specificities and likelihood ratios of a point-of-care turbidimetric assay 
(POC-TIAb) and point-of-care ELISA (POC-ELISAa) to detect RID IgG concentrations ≤800 











































































AUC, area under the curve of ROC curve analysis; CI, confidence intervals; LR, likelihood 
ratio; RID, radial immunodiffusion; FTPI: failure of transfer of passive immunity 





Figure 1 Regression lines (solid lines) and 95% confidence intervals (dashed lines) showing 
the relation between observed and expected IgG concentrations measured using the point-of-
care turbidimetric assay (POC-TIA) assay obtained after dilution of two plasma samples (A 






Figure 2 Bland-Altman plots showing agreement of the point-of-care turbidimetric assay 
(POC-TIA) with radial immunodiffusion (RID) for IgG concentrations in samples with RID 
concentrations <400 mg/dL (A), 400–800 mg/dL (B) and >800 mg/dL (C). The solid line 
represents the mean bias; the two dashed lines represent the 95% limits of agreement and the 




Figure 3 Receiver-operator characteristic curves for the point-of-care turbidimetric assay 
(POC-TIA) to detect IgG concentrations of <400 mg/dL (A) and ≤800 mg/dL (B) measured 





Figure 4 Receiver-operator characteristic (ROC) curves for the point-of-care ELISA (POC-
ELISA) to detect IgG concentrations of <400 mg/dL (A) and ≤800 mg/dL (B) measured with 
radial immunodiffusion. ROC curves for were calculated from the predicted probabilities 
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